Cormorant Asset Management, LP - Mar 31, 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: VYNE
Shares outstanding: 18.5M shares
Disclosed Ownership: 1.85M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Date filed: 5/19/2025, 05:47 PM
Date of event: Mar 31, 2025
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	9.99%	1.85M	0	1.85M	By: /s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	9.99%	1.85M	0	1.85M	/s/ Bihua Chen	Bihua Chen